Sa te yon peryòd ki bay anpil moun estrès, men jwenn aksè nan nouvo vaksen yo enpòtan e se etap ki enteresan nan lit nou avèk COVID-19 la pou nou retounen nan lavi nòmal la. Pou ede nou adrese kesyon sou vaksen ki disponib pou moun kounye a, men kèk reyalite ki soti bò kote doktè ki nan Tufts Medical Center’s Infectious Diseases (Sant Medikal pou Maladi Enfeksyon Tufts):

The active ingredient in the vaccine has instructions for your cells on how to make a piece of the “spike protein” that is unique to the virus that causes COVID-19. The "spike protein" makes your immune system “think” your body has the disease even though it really doesn’t. This causes the immune system to produce antibodies and protect you from the real virus if you are exposed.

Yes. The COVID-19 vaccines currently available (Pfizer and Moderna) are given to people in two doses, 21 (Pfizer) or 28 (Moderna) days apart. The effectiveness of the vaccines has only been studied after two doses.

No. You cannot develop COVID-19 disease from the vaccine.

Yes, the COVID-19 vaccines available (Pfizer and Moderna) have been thoroughly tested as part of clinical trials. The Food and Drug Administration (FDA) and a group of vaccine experts from throughout the country carefully reviewed information. The FDA then decided it was safe to make the Moderna vaccines available to persons aged 18 years and older. The Pfizer vaccine can be used in people 16 and older.  

The FDA’s review of the vaccines was thorough and rigorous, and no steps were skipped in the process to review the safety of the vaccines. The FDA decided that the vaccine met safety and efficacy standards based on the currently available data from more than 43,000 diverse volunteers, and it was felt the benefits of the vaccine outweighed any side effects.

The most commonly reported side effects are soreness at the site of the injection as well as flu-like symptoms, including fatigue, body aches, chills or fevers after the vaccine. Side effects were most common after the second dose of the vaccine, and more likely to be experienced by younger people. These symptoms go away within the first few days after receiving the vaccine. The side effects tell us that the body is building protection against the virus.

To date, people who have had allergic reactions to the vaccine have all recovered quickly. This risk of allergic reaction is very small and is similar to the risk of allergic reaction associated with all medications and vaccines.

Because it is safe to receive the vaccine even if you have active or recent COVID-19, you do not need to take a test. However, if you know that you have active COVID-19, we ask that you delay your vaccination until you are released from isolation so that you are no longer contagious to others.

Yes. We simply ask that you delay your vaccination until you are released from isolation so that you are no longer contagious to others. Please schedule dose 2 for as soon as possible after your release from isolation.

Yes. Pregnant individuals are at a higher risk of getting severe COVID-19. For this reason, the Society for Maternal-Fetal Medicine and American College of Obstetricians and Gynecologists strongly recommends that pregnant individuals have access to COVID-19 vaccines and that each person has a discussion with their health care professional about their own personal choice. For more information about COVID-19 vaccines and pregnancy, go to this link.

Yes. The Society for Maternal-Fetal Medicine reports that there is no reason to believe that the vaccine affects the safety of breastmilk. For more information, go to this link.

Yes. Both vaccines are not recommended for persons with history of severe allergic reaction (e.g. anaphylaxis) to any component of the vaccine, any persons with a history of immediate allergic reaction to any mRNA vaccine, and a history of immediate allergic reaction to polysorbate. If you have had an immediate allergic reaction to polyethylene glycol (PEG, a component of the vaccines) or polysorbate (chemically related to PEG), the CDC recommends an evaluation by an allergist/immunologist to determine if you can receive the vaccine safely.

CDC considers a history of immediate allergic reaction to another vaccine or injectable therapy, or a history of anaphylaxis due to any cause to be a precaution. People who have these reactions should be observed for 30 minutes (rather than 15) after each dose of vaccine. 

Allergic reactions (including severe allergic reactions) not related to vaccines or injectable therapies (e.g., food, pet, venom, environmental or latex allergies; oral medications [including the oral equivalents of injectable medications]) are not a contraindication or precaution to vaccination with mRNA COVID-19 vaccines. For more information, see CDC Vaccines & Immunizations

Wi. Moun ki ansent yo gen pi gwo risk pou yo malad anpil nan COVID-19. Pou rezon sa a, CDC, Society for Maternal-Fetal Medicine ak American College of Obstetricians and Gynecologists fòtman rekòmande pou moun ki ansent gen aksè nan vaksen COVID-19 la e chak moun gen yon diskisyon ak pwofesyonèl swen sante yo sou chwa pèsonèl yo. Pou plis enfòmasyon sou vaksen COVID-19 ak gwosès, ale nan lyen sa a.

Wi. CDC ak Society for Maternal-Fetal Medicine rapòte p at gen okenn rezon pou w kwè vaksen an afekte lèt tete a. Pou w plis enfòmasyon, ale nan lyen sa a.

Non, prekosyon/deklarasyon alèji yo diferan pou chak vaksen. Moun ki konnen yo fè alèji ak Polyethylene Glycol (PEG) pa dwe pran vaksen Pfizer oswa Moderna. Moun ki konnen yo fè alèji ak polysorbate pa dwe pran vaksen Janssen (Johnson & Johnson) nan. Si w te gen yon gwo reyaksyon alèji imedya ak yon premye dòz nan vaksen Moderna oswa Pfizer a, ou kapran vaksen Janssen (Johnson & Johnson) nan kòm yon dezyèm dòz. Li enpòtan pou w diskite sa ak doktè premye swen w.

Lòt kalite enfòmasyon alèji, tankou yon reyaksyon imedya nan yon lòt vaksen oswa terapi enjeksyon, oswa yon istwa anafilaksi pou nenpòt ki rezon konsidere tankou yon prekosyon pa CDC. Moun ki gen reyaksyon sa yo dwe pran vaksen yo, men yo dwe obsève yo pou 30 minit (olye de 15) apre chak dòz vaksen.

Reyalèji yo (enkli gwo reyaksyon alèji) ki pa ren rapò ak vaksen oswa terapi enjeksyon (tankou reyasyon ak manje, bèt, venen, alèji ak latèks oswa anviwonman, oswa medikaman oral ki gen ladann ekivalan oral medikaman enjeksyon) pa yon kontendikasyon oswa prekosyon pou vaksen COVID-19 yo. Pou plis enfòmasyon, gade Vaksen ak Iminizasyon yo CDC yo.

The Massachusetts Department of Health is developing a plan to vaccinate everyone in the state who wants to be vaccinated. Doing so will take several months. They have prioritized certain groups including health care workers, first responders, those over 75, etc. To see the state’s latest timeline, go here.

The Massachusetts Department of Health is developing a plan to vaccinate everyone in the state who wants to be vaccinated. Doing so will take several months. They have prioritized certain groups including health care workers, first responders, those over 75, etc. To see the state’s latest timeline, go here (mass.gov/covidvaccine).  

Social media can easily and quickly spread information, including false information. It is always important to check the source of information. The CDC has provided excellent and trusted resources for questions about the current COVID-19 vaccines here; information from the FDA in multiple languages can be found here and is also very helpful. Your doctor can also talk to you more about the vaccine.

There are no differences in travel guidelines or restrictions based on vaccine status. Please check the latest travel guidelines from the state.

Depatman Sante Piblik eta a te bay direktiv pou ki lè moun ka pran vaksen. Moun nan gwoup Faz 1 ak Faz 2 ka pran yon vaksen kounye a. Ou kapab jwenn plis detay sou ki lè ak ki kote pou w pran vaksen an nan https://www.mass.gov/covid-19-vaccine.

Medya sosyal ka pwopaje enfòmasyon byen vit ak byen fasil, enkli enfòmasyon ki fo. Li toujou enpòtan pou tcheke sous enfòmasyon an. CDC te bay bonjan kalite resous pou kesyon sou vaksen aktyèl COVID-19 yo isit la; nou kapab jwenn enfòmasyon nan FDA nan plizyè langa isit la e li byen itil tou. Doktè w kapab apele avèk ou plis sou vaksen an. Tanpri vizite www.Wellforce.org/covidvaccine pou w jwenn videyo ak lòt enfòmasyon nan plizyè langaj.

Paske Etazini toujou wè go nivo aktivite COVID-19, espè sante piblik eta, nasyonal yo kontinye ankouraje Ameriken pou evite toude vwayaj dometik ak etranje. CDC dènyèman te ofri nouvo gid vwayaj pou moun ki vaksinen yo isit la. Kèk eta nan Etazini te ajiste restriksyon vwayaj yo. Tcheke direktiv pou eta w ap vizite a. Epitou tcheke isit la pou w jwenn dènye direktiv vwayaj nan eta Massachusetts.